LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 38 filers reported holding LUMOS PHARMA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,544,879 | 0.0% | 468,145 | 0.0% | 0.01% | -14.3% |
| Q2 2023 | $1,544,879 | -0.3% | 468,145 | 0.0% | 0.01% | +16.7% |
| Q1 2023 | $1,549,560 | -8.3% | 468,145 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $1,690,003 | +40691.8% | 468,145 | 0.0% | 0.01% | -60.0% |
| Q3 2022 | $4,143 | -99.9% | 468,145 | 0.0% | 0.02% | +25.0% |
| Q2 2022 | $3,605,000 | -18.1% | 468,145 | 0.0% | 0.01% | +9.1% |
| Q1 2022 | $4,401,000 | +35.7% | 468,145 | 0.0% | 0.01% | +37.5% |
| Q4 2021 | $3,244,000 | -27.1% | 468,145 | 0.0% | 0.01% | -20.0% |
| Q3 2021 | $4,452,000 | -4.9% | 468,145 | 0.0% | 0.01% | -9.1% |
| Q2 2021 | $4,681,000 | -14.5% | 468,145 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $5,477,000 | -67.2% | 468,145 | 0.0% | 0.01% | -81.4% |
| Q4 2020 | $16,717,000 | +158.4% | 468,145 | 0.0% | 0.06% | +136.0% |
| Q3 2020 | $6,470,000 | -16.2% | 468,145 | 0.0% | 0.02% | -24.2% |
| Q2 2020 | $7,720,000 | +94.0% | 468,145 | 0.0% | 0.03% | +13.8% |
| Q1 2020 | $3,979,000 | – | 468,145 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PVG ASSET MANAGEMENT CORP | 10,175 | $70,512,000 | 0.26% |
| Minerva Advisors LLC | 34,015 | $236,000 | 0.14% |
| Investors Financial Group, LLC | 30,600 | $212,000 | 0.10% |
| Lion Point Capital, LP | 51,205 | $354,000 | 0.10% |
| NEA Management Company, LLC | 376,916 | $2,612,000 | 0.05% |
| Wealth Advisors of Iowa, LLC | 11,699 | $81,000 | 0.04% |
| Paladin Advisory Group, LLC | 4,382 | $30,000 | 0.02% |
| Marquette Asset Management, LLC | 13,315 | $92,000 | 0.02% |
| Blackstone Inc. | 468,145 | $3,244,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 47,643 | $331,000 | 0.01% |